Cannara Biotech Inc.
LOVFF
Rank in Stocks
#18161
Cannara Biotech Inc., alongside its affiliated entities, specializes in the... Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Share Price
$1.49
Last synced: 2026-11-09
Market Cap
$142.70M
Change (1 day)
-1.71%
Change (1 year)
26.61%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cannara Biotech Inc. (LOVFF)
Category
Healthcare
Operating Margin for Cannara Biotech Inc. (LOVFF)
Operating Margin as of November 2026 TTM: 0.10%
According to Cannara Biotech Inc.'s latest financial reports, its current operating margin (TTM) is 0.10%. At the end of 2025 the company had an operating margin of 20.68%.
Operating Margin history for Cannara Biotech Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.10% | -99.52% |
| 2025 | 20.68% | 67.72% |
| 2024 | 12.33% | -40.61% |
| 2023 | 20.76% | 102.54% |
| 2022 | 10.25% | 807.08% |
| 2021 | 1.13% | -100.24% |
| 2020 | -467.66% | -4.07% |
| 2019 | -487.52% | 16.07% |
| 2018 | -420.01% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | 94.10% |
DE
|
|
| 19.68% | 96.80% |
DE
|
|
| 13.26% | 32.60% |
JP
|
|
| 17.08% | 70.80% |
CH
|
|
| 14.92% | 49.20% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cannara Biotech Inc.'s operating margin
What is Cannara Biotech Inc.'s operating margin?
Cannara Biotech Inc.'s operating margin is 0.10%, as of Nov 2026.
What was Cannara Biotech Inc.'s operating margin in 2025?
In 2025, Cannara Biotech Inc.'s operating margin was 20.68%, compared with 12.33% in 2024.
How has Cannara Biotech Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cannara Biotech Inc.'s operating margin was highest in 2023 (20.76%) and lowest in 2020 (-467.66%).
How does Cannara Biotech Inc.'s operating margin compare with similar companies?
Cannara Biotech Inc.'s operating margin (0.10%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.